MiMedx Group, Inc. Unrecognized Tax Benefits
MiMedx Group, Inc. (MDXG) had Unrecognized Tax Benefits of $862.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefits · last filed 2026-02-25
- 2025-12-31: Unrecognized Tax Benefits $862.00K.
- 2024-12-31: Unrecognized Tax Benefits $831.00K.
- 2023-12-31: Unrecognized Tax Benefits $807.00K.
- 2022-12-31: Unrecognized Tax Benefits $645.00K.
| Period end | Unrecognized Tax Benefits | Unrecognized Tax Benefits as first filed |
|---|---|---|
| 2025-12-31 | $862.00K 10-K · filed 2026-02-25 | |
| 2024-12-31 | $831.00K 10-K · filed 2026-02-25 | |
| 2023-12-31 | $807.00K 10-K · filed 2026-02-25 | |
| 2022-12-31 | $645.00K 10-K · filed 2026-02-25 | |
| 2021-12-31 | $469.00K 10-K · filed 2025-02-26 | |
| 2020-12-31 | $477.00K 10-K · filed 2024-02-28 | |
| 2019-12-31 | $627.00K 10-K · filed 2023-02-28 | |
| 2018-12-31 | $938.00K 10-K · filed 2022-02-28 | |
| 2017-12-31 | $847.00K 10-K · filed 2021-03-08 | |
| 2016-12-31 | $336.00K 10-K · filed 2020-07-06 | $281.00K 10-K · filed 2017-03-01 |
| 2015-12-31 | $170.00K 10-K · filed 2020-03-17 | |
| 2014-12-31 | $0.00 10-K · filed 2017-03-01 | |
| 2013-12-31 | $0.00 10-K · filed 2017-02-22 | |
| 2012-12-31 | $18.82M 10-K · filed 2013-03-15 | |
| 2011-12-31 | $15.45M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |